Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact
Search
Close

AnJie Broad Partners at ABA Asia-Pacific Forum in Singapore

By Hao Zhan & Ying Song on March 17, 2025
Email this postTweet this postLike this postShare this post on LinkedIn

From 26 to 28 February 2025, Dr Zhan Hao and Ms Song Ying, partners at AnJie Broad Law Firm, participated in the ABA Asia-Pacific Conference held in Singapore Management University.

Bringing together over 200 legal professionals from around the world, the conference served as a platform for in-depth discussions on key legal and regulatory developments in the Asia-Pacific region. Covering topics such as AI, Competition Law, Corporate Transactions, Dispute Resolution, Legal Ethics, Restructuring and Technology, and Trade and Sanctions, the forum facilitated valuable exchanges on emerging trends and practical challenges.

Dr Zhan Hao contributed as a speaker in the panel discussion “Convergence or Conflict: Decoding the New Balance Between Antitrust and Intellectual Property in Asia.” In this session, the experts from various jurisdictions deeply explored the evolving intersection of antitrust and intellectual property rights across jurisdictions such as China, South Korea, Japan, Singapore, and Australia. Discussions highlighted recent precedents and legislative changes, focusing on the challenges faced by innovation-intensive industries like high-tech and pharmaceuticals amid increasing antitrust scrutiny in global mergers, governmental investigations, and antitrust litigations.

Dr Zhan Hao shared insights on the evolving relationship between intellectual property (IP) and competition law and emphasized the importance of balancing innovation incentives with fair competition principles. Particularly, he stressed China’s Supreme People’s Court’s (SPC) constant efforts to refine the application rules of antitrust law in IP matters, highlighted the landmark cases such as Hitachi Metal and Huaming. Dr Zhan also addressed the increasing focus on standard essential patents (SEPs) and the potential rise in private antitrust litigation in China. Also, he advised stakeholders in the pharmaceutical and technology sectors to closely follow upcoming antitrust guidelines and heightened scrutiny in merger reviews. The attendees highly appreciated Dr Zhan Hao’s presentation and applauded for his in-depth analysis and practical perspectives, which added valuable insights to the forum.

The event also provided opportunities to strengthen professional exchanges and communications through various networking sessions and evening gatherings at the Singapore Supreme Court and the Singapore Cricket Club.

We appreciate the opportunity to exchange insights with our global peers and look forward to continuing these conversations. Let’s stay connected!

Photo of Hao Zhan Hao Zhan
Email
Photo of Ying Song Ying Song
Email
  • Posted in:
    Antitrust, Competition and Trade, Business and Commercial, Technology and AI
  • Blog:
    China Law Vision
  • Organization:
    AnJie Broad Law Firm
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
The Library at LexBlog
  • About LexBlog
  • The Field We Built
  • Library at LexBlog
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo